American Society for Reproductive Medicine

Clinics within The Prelude Network ® Recognized by the Society for Assisted Reproductive Technology for Excellence in Fertility Care Services and Reporting

Retrieved on: 
Tuesday, November 7, 2023
Science, American Society for Reproductive Medicine, SART, Fertility, Inception, RBA, Fertility clinic, Health, Society, ART, Reproductive medicine, IVF, Quality assurance, Dream, REI, Assisted reproductive technology, Partner, ASRM, Woman, Safety, Patient, Human Biology Association, Reproductive endocrinology and infertility, Parent, Birth control, Nursing

HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.

Key Points: 
  • HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network ®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.
  • This recognition is a joint selection by SART's Quality Assurance and Validation Committees to recognize clinics for their excellence in prospective reporting and for following guidance set forth by the American Society for Reproductive Medicine (ASRM) and SART.
  • "It is a testament of their dedication to patients and the field of reproductive medicine to uphold, practice, and deliver the highest standards in fertility care."
  • The clinic provides patient-centric, individualized care that offers patients the latest science and technologies in fertility medicine.

Reimagining Parenthood: Redefining Infertility to Celebrate Every Surrogacy Journey

Retrieved on: 
Monday, November 6, 2023
Fertility, Donor conceived person, Insurance, Anton Carl Illum, American Society for Reproductive Medicine, Open Door, Family Equality Council, History, Family, Hope, Parent, Marital status, Society, Multimedia, Reproductive medicine, Pregnancy, Private law, ASRM, LGBT, Single parent, Infertility, Birth control

This new inclusive definition for infertility will allow more people to fulfill their dreams of parenthood.

Key Points: 
  • This new inclusive definition for infertility will allow more people to fulfill their dreams of parenthood.
  • As Fontes states, "We have always believed everyone who wants to be a parent should be able to.
  • This change is particularly significant, given that some insurance plans rely on ASRM's definition of infertility to approve fertility treatments.
  • As a gay dad myself, I understand how hard it is to get started on a surrogacy journey.

Military Families Campaign Raises Awareness of Infertility in the Military Community, Expands Access to Quality Care to Veterans and Active-Duty Service Members

Retrieved on: 
Wednesday, November 1, 2023
American Society for Reproductive Medicine, National Veterans Memorial and Museum, Desert Uniforms, Patches, and Insignia of the US Armed Forces, Fertility, Inception, Military personnel, Fertility clinic, Parent, Veteran, Society, United States Department of Veterans Affairs, Practice, Learning, Reproductive medicine, IVF, Pregnancy, Aspire, REI, ASRM, Woman, Patient, IUI, Reproductive endocrinology and infertility, Infertility, VA, Health insurance, Birth control, Nursing, Prelude

HOUSTON, Nov. 1, 2023 /PRNewswire/ -- In celebration of National Veteran and Military Families Month  The Prelude Network® (Prelude) honors the members of the US Armed Forces by expanding accessibility to premium reproductive services to veterans and active-duty personnel through its Military Families Month campaign.

Key Points: 
  • HOUSTON, Nov. 1, 2023 /PRNewswire/ -- In celebration of National Veteran and Military Families Month The Prelude Network ® (Prelude) honors the members of the US Armed Forces by expanding accessibility to premium reproductive services to veterans and active-duty personnel through its Military Families Month campaign.
  • Historically, accessing fertility services has been limited for service members as they must meet stringent criteria set by the Department of Veterans Affairs (VA).
  • "Through our Military Families campaign, Inception is doing its part honor, serve, and support our military members by helping improve that accessibility."
  • For active and retired service members interested in learning more about Prelude's Military Families Month offer, please visit Prelude's Military Families Campaign page.

Gameto Unveils New Data on In Vitro Maturation Product Candidate Fertilo During Four Presentations at the 2023 American Society for Reproductive Medicine

Retrieved on: 
Thursday, October 19, 2023
Gold, Human, Cell engineering, Fertility, RMA, IVM, RNA, Biotechnology, Spindle apparatus, Congress, Research, Society, F1, Reproductive medicine, IVF, Egg, Oocyte, Cell, Partnership, Behavior informatics, Abstract, American Society for Reproductive Medicine, ASRM, Woman, Safety, Patient, Gene expression, Mineral oil

Gameto's findings show their product candidate, Fertilo, is able to improve egg maturation and embryo development in shortened human minimal stimulation cycles.

Key Points: 
  • Gameto's findings show their product candidate, Fertilo, is able to improve egg maturation and embryo development in shortened human minimal stimulation cycles.
  • The combined findings are an important evidence package as a next step in advancing this reproductive technology.
  • NEW YORK, Oct. 19, 2023 /PRNewswire/ -- Gameto, a female-led biotechnology company with a mission to redefine women's healthcare, presented four abstracts at the 2023 American Society for Reproductive Medicine (ASRM) Congress.
  • The findings show that Fertilo not only matures more eggs, but results in better gene expression and genetic health quality than traditional IVM.

Boston IVF Showcases Pioneering Fertility Research at the 2023 ASRM Scientific Congress & Expo

Retrieved on: 
Thursday, October 19, 2023
Embryology, Knowledge, Patient, Protocol, Research, Harvard Medical School, American Association of Clinical Endocrinologists, MPH, Beth Israel Deaconess Medical Center, Clinical research, Hope, RESEARCH, Congress, 2001 Slovenian fertility treatment referendum, Probability, Impact, MBA, Health, Episcopal conference, Society, Male, Reproductive medicine, IVF, Partnership, Abstract, Merck Serono, Cryopreservation, Comparison, American Society for Reproductive Medicine, ASRM, Expo, Diversity, IUI, Infertility, Nursing, Pharmaceutical industry, Mineral oil, Birth control, Fertility, MD, Doctor of Philosophy

BOSTON, Oct. 19, 2023 /PRNewswire-PRWeb/ -- Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.

Key Points: 
  • Charting a Path to Tomorrow, Boston IVF's Groundbreaking Research in 2023 Continues to Shape the Future of Fertility Care
    BOSTON, Oct. 19, 2023 /PRNewswire-PRWeb/ -- Boston IVF , a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo .
  • – David Stern, CEO of Boston IVF
    Boston IVF's team of reproductive endocrinologists, scientists, clinicians, and researchers presented over 20 pioneering research studies, along with education symposia and roundtables.
  • This year, four distinguished individuals from Boston IVF were recognized nationally by the ASRM for their exceptional contributions:
    Yuval Fouks, MD, PhD, MPH a dedicated Research Fellow at Boston IVF, was honored with the ASRM 2023 IN TRAINING AWARD FOR RESEARCH for his noteworthy publication in Fertility and Sterility.
  • (Source: Fertility & Sterility)
    Quetrell Heyward, MD, MBA, a Reproductive Endocrinology and Infertility Fellow at Boston IVF & Beth Israel Deaconess Medical Center, received the prestigious ASRM 2023 INVESTIGATOR ACHIEVEMENT AWARD.

Chief Research Officer at US Fertility, Kate Devine, M.D., receives prestigious award from ASRM

Retrieved on: 
Wednesday, October 18, 2023
American Society for Reproductive Medicine, SART, Publishing, Ira, Fertility, Medical director, Congress, K Street, Yale Physician Associate Program, Research, SGF, Society, Letter, Reproductive medicine, LOS, Assisted reproductive technology, ASRM, Opening ceremony, NIH, Georgetown University School of Medicine, Patient, Bangladesh Technical Education Board, Birth control, Pharmaceutical industry, Medicine, Infertility

LOS ANGELES, Oct. 18, 2023 /PRNewswire-PRWeb/ -- US Fertility celebrates, Kate Devine, M.D., Medical Director and Chief Research Officer, who received the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.

Key Points: 
  • , Medical Director and Chief Research Officer, who received the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.
  • "I am incredibly humbled to receive such an honor and send gratitude to ASRM and my physician peers who have supported me," shares Dr. Devine.
  • The award was announced during ASRM's Opening Ceremony on Monday, October 16, 2023 and presented during the ASRM Research Symposium on Wednesday, October 18, 2023.
  • Learn more about US Fertility's Research Division , which conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to infertility patients.

IVIRMA Research Presented at ASRM 2023 Shapes the Future of Reproductive Medicine

Retrieved on: 
Wednesday, October 18, 2023
Aneuploidy, Mosaic, Research, Genetic counseling, Intelligence, Genetic testing, RMA, BMI, Ovarian reserve, Library branch, FET, Society, CPL, Yoshinori Ohsumi, Reproductive medicine, IVF, SWE, Risk, Pregnancy, BPL, ASRM, Patient, American Society for Reproductive Medicine, Abram Ilyich Fet, Birth control

BASKING RIDGE, N.J., Oct. 18, 2023 /PRNewswire/ -- IVIRMA Global, the largest reproductive medicine group in the world, has a long history of pioneering research in the field of assisted reproductive technologies that has led to major advances in assisted reproduction. Many of today's standard practices, including elective single embryo transfer and preimplantation genetic testing for aneuploidy, have been shaped by the fertility group's innovative research efforts. 

Key Points: 
  • Many of today's standard practices, including elective single embryo transfer and preimplantation genetic testing for aneuploidy, have been shaped by the fertility group's innovative research efforts.
  • At the recently concluded American Society of Reproductive Medicine (ASRM) 2023 conference in New Orleans, investigators from the IVIRMA Global Research Alliance contributed further to the field, presenting 37 separate studies addressing clinically important questions that will continue to improve outcomes and help patients successfully grow their families.
  • Researchers from Reproductive Medicine Associates (RMA), the U.S. arm of IVIRMA Global, presented new research that could change fertility specialists' understanding of the factors impacting successful implantation, pregnancy and live birth.
  • A prior IVIRMA study had shown that there's a 95% chance of achieving a pregnancy in patients undergoing up to three consecutive single euploid embryo transfers.

ARC® Fertility Leadership to Support ASRM Congress, October 14-18

Retrieved on: 
Saturday, October 14, 2023
Research, General Health, Professional Services, Family, Consumer, DEI (Diversity, Equity and Inclusion), Parenting, Health Insurance, Science, Baby, Maternity, Human Resources, Health, Congress, Reproductive medicine, IVF, Society, USA Today, ARC, ASRM, Publication, Episcopal conference, American Society for Reproductive Medicine, Racism, Fertility

ARC Fertility , a pioneer in innovative fertility and family-forming treatment options, will proudly be supporting the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress and Expo in New Orleans.

Key Points: 
  • ARC Fertility , a pioneer in innovative fertility and family-forming treatment options, will proudly be supporting the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress and Expo in New Orleans.
  • A longtime supporter of ASRM, ARC Fertility founder and CEO Dr. G. David Adamson previously served as president for the society.
  • He’ll be joined by ARC leadership for this year’s program.
  • “ASRM members are advancing medical science and delivering vital new marketplace solutions every day, and the annual ASRM Congress is critical to our field’s ongoing progress.

US Fertility's research team demonstrates commitment to improving outcomes for fertility patients at this year's ASRM Scientific Congress

Retrieved on: 
Monday, October 16, 2023
Congress, Partnership, Knowledge, Physician, Abstract, Reproductive medicine, IVF, REI, Society, IUI, The Pipeline, Fertility, ART, Patient, Nursing, Region, SGF, Biostatistics, ASRM, Publication, Infertility, The Denial of the Historicity of Jesus in Past and Present, Reproduction, FCI, San Francisco Bay Area, American Society for Reproductive Medicine, Research, Birth control, Pharmaceutical industry

NEW ORLEANS, Oct. 16, 2023 /PRNewswire-PRWeb/ -- US Fertility's research team will present over 60 abstracts during the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo as part of its commitment to advancing knowledge and improving assisted reproductive technology (ART) treatment outcomes.

Key Points: 
  • US Fertility's physician-scientists will present over 60 studies at this year's American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo.
  • NEW ORLEANS, Oct. 16, 2023 /PRNewswire-PRWeb/ -- US Fertility's research team will present over 60 abstracts during the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo as part of its commitment to advancing knowledge and improving assisted reproductive technology (ART) treatment outcomes.
  • "As the largest partnership of physician-owned fertility practices in the United States, US Fertility is leading the way in reproductive medicine research."
  • "As the largest partnership of physician-owned fertility practices in the United States, US Fertility is leading the way in reproductive medicine research," shares Kate Devine, M.D.

ASRM ANNOUNCES HISTORIC $5 MILLION ENDOWMENT FROM FERRING PHARMACEUTICALS

Retrieved on: 
Monday, October 16, 2023
Congress, Ferring Pharmaceuticals, Parent, Hospital, MBA, AUC, Hope, Reproductive medicine, Economics, Education, MD, Caregiver, REI, Society, American Society for Reproductive Medicine, Workforce, Growth, Golden Joystick Awards, ASRM, History, Corporate Affairs, Health professional, Infertility, Physician, Nursing, Management

WASHINGTON and PARSIPPANY, N.J., Oct. 16, 2023 /PRNewswire/ -- The American Society for Reproductive Medicine (ASRM) and Ferring Pharmaceuticals today announced a historic $5 million endowment from Ferring to ASRM.  This endowment, the largest in ASRM's nearly 80-year history, will establish the "Ferring Endowment for the Education of Healthcare Professionals in Training," ensuring ASRM's continued legacy as the leading educator for professionals in the field.

Key Points: 
  • WASHINGTON and PARSIPPANY, N.J., Oct. 16, 2023 /PRNewswire/ -- The American Society for Reproductive Medicine (ASRM) and Ferring Pharmaceuticals today announced a historic $5 million endowment from Ferring to ASRM.
  • This endowment, the largest in ASRM's nearly 80-year history, will establish the "Ferring Endowment for the Education of Healthcare Professionals in Training," ensuring ASRM's continued legacy as the leading educator for professionals in the field.
  • We're honored to partner with ASRM to augment their learning opportunities at this important stage of their careers," said Jade Levi Shields, Vice President, Corporate Affairs, Ferring Pharmaceuticals.
  • "ASRM is immensely grateful to Ferring for this generous endowment that will address the longstanding need for more early career training in reproductive medicine.